A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-Injector

INTRODUCTION: It is important to achieve good persistence and adherence to disease-modifying therapies (DMTs) to achieve the best outcomes in chronic diseases such as multiple sclerosis (MS). The BETACONNECT device is an electronic auto-injector for the DMT interferon beta-1b (Betaseron), designed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Farej, Ryan, Rametta, Mark, La Rose, Anneliese, Quillen, Apryl, McLeod, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857376/
https://www.ncbi.nlm.nih.gov/pubmed/35064907
http://dx.doi.org/10.1007/s40120-022-00323-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857376/
https://www.ncbi.nlm.nih.gov/pubmed/35064907
http://dx.doi.org/10.1007/s40120-022-00323-1

Ejemplares similares